53. 高彥偉; 俞友根, 吳茱萸外用治療皮膚病, 四川中醫, 1993, 11, 56-59.
54. Chen, G. L.; Yuan, Y. C.; Li, Y. F.; Lee, A. R.; Chen, C. F. A stability indicating method for dehydroevodiamine chloride by high-performance liquid chromatography/diode array detector, J Chin Pharm, 1991, 43, 75-80.
55. Peng, Y. T.; Shum, A. Y. C.; Tsai, T. H.; Lin, L. C.; Chen, C. F. High-performance liquid chromatography of the quinazolinocarboline alkaloid dehydroevodiamine, J Chromatogr, 1993, 617, 87-93.
56. Ko, H. C.; Tsai, T. H.; Chou, C. J.; Hsu, S. Y.; Li, S. Y.; Chen, C. F. High-performance liquid chromatographic determination of rutaecarpine in rat plasma, application to pharmacokinetic study, J Chromatogr, 1994, 655, 27-31.
57. Jeng, K. F.; Lin, Y. H.; Lin, L. C.; Chou, C. J.; Tsai, T. H.; Chen, C. F. High-performance liquid chromatographic determination of evodiamine in rats plasma, application to
pharmacokinetic studies, J Chromatogr. B, 1995, 668, 343-345.
58. Yu, L. L.; Ho, L. k.; Liao, J. F.; Chen, C. F. 6-Methoxy-N-methyl-1,2,3,4-tetrahydro-β -carboline from Evodiae Fructus, Planta Med., 1997, 63, 471-472.
59. Yu, L. L.; Ho, L. K.; Liao, J. F.; Chen, C. F. Two 5-HT1A receptor-interactive tryptamine derivatives from theunripe fruit of Evodia rutaecarpa, J Nat Prod, 1997, 60, 1196-1198.
60. Chen, C. F.; Chiou, W. F.; Chou, C. J.; Liao, J. F.; Lin, L. C.; Wang, G. J.; Ueng, Y. F.
Pharmacological effects of Evodia rutaecarpa and its bioactive components, Chin Pharm J, 2002, 54, 419-435.
61. 黃慧蓮; 劉賢旺; 羅光明; 張壽文, 吳茱萸研究進展, 現代中藥研究與實踐, 2003, 17, 62-64.
62. Zhan, G. X.; Wu, D. Z.; Hu, Z. B. Advancement of pharmacological research on the effective components in Fructus Evodiae, S H J TCM, 2006, 40, 62-64.
63. Yang, H. Y.; Li, S. Y.; Chen, C. F. Hypotensive effects of dehydroevodiamine, a
quinazolinocarboline alkaloid isolated from Evodiae rutaecarpa, Asia Pac J Pharmacol, 1988, 3, 191-196.
64. Yang, M. C. M.; Wu, S. L.; Kuo, J. S.; Chen, C. F. The hypotensive and negative chronotropic effects of dehyfroevodiamine, Eur J Pharamcol, 1990, 182, 537-542.
65. Lin, C. I.; Loh, S. H.; Luk, H. N.; Lue, W. M.; Chen, C. F. Electropharmacological effects of dehydroevodiamine on mammalian hearts, J Chin Med, 1990, 1, 84-93.
66. Chiou, W. F.; Sung, Y. J.; Liao, J. F.; Chen, C. F. Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages, J Nat Prod, 1997, 60, 708-711.
67. Lim, D. K.; Lee, Y. B.; Kim, H. S. "Effects of dehydroevodiamine exposure on glutamate release and uptake in the cultured cerebellar cells", Neurochem Res, 2004, 29, 407-411.
68. Rang, W. Q.; Du, Y. H.; Hu, C. P. Protective effects of evodiamine on myocardial ischemia- reperfusion injury in rats, Planta Med, 2004, 70, 1140-1143.
69. Hung, P. H.; Lin, L. C.; Wang, G. J. Inhibitory effect of evodiamine on aldosterone release by Zona glomerulosa cells in male rats, Chin J Physiol, 2001, 44, 53-57.
70. Yoshizumi, M.; Houchi, H.; Ishimura, Y. Effect of evodiamine on catecholamine secretion from bovine adrenal medulla, Med Invest, 1997, 44, 79-82.
71. Lin, H.; Tsai, S. C.; Chen, J. J. Effects of evodiamine on the secretion of testosterone in rat testicular interstitial cells, Metabolism, 1999, 48, 1532-1535.
72. Yasunari, T.; Kobayashi, Y.; Aggarwal, B. B. Evodiamine abolishes constitutive and inducible NF -βactivation by inhibiting IB kinase activation, thereby suppressing NF-β -regulated antiapoptotic and metastatic gene expression, up- regulating apoptosis, and inhibiting invasion. J Biol Chem, 2005, 280, 203-212.
73. Liao, C. H.; Pan, S. L.; Guh, J. H. Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae Fructus, in human multiple drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo, Carcinogenesis, 2005, 26, 968-975.
74. Huang, D. M.; Guh, J. H.; Huang, Y. T. Induction of mitotic arrest and apoptosis in human prostate cancer pc - 3 cells by evodiamine, J Urol, 2005, 173, 256-261.
75. Kobayashi, Y.; Nakano, Y.; Hoshikuma, K. The bronchoconstricttive action of evodiamine, an indoloquinazoline alkaloid isolated from the fruits of Evodia rutaecarpa, on guineapig isolated bronchus, possible involvement on vanilloid receptors, Planta Med, 2000, 66, 526-530.
76. Chiou, W. F.; Chen, C. F. Pharmacological profile of evodiamine in isolated rabbit corpus cavernosum, Eur J Pharmacol, 2002, 446, 151-159.
77. Wu, C. L.; Hung, C. R.; Chang, F. Y.; Lin, L. C.; Pau, K. Y. F.; Wang, P. S. Effects of evodiamine on gastrointestinal motility in male rats, Eur J Pharmacol, 2002, 457, 169-176.
78. Lin, C. I.; Kuo, C. C.; Lin, T. C.; Chen, C. F. "Electromechanical effects of evodiamine in guinea-pig cardiac tissues", Asia Pac J Pharmacol, 1994, 9, 153-161.
79. Wang, G. J.; Shan, J. Pang, P. K. T.; Yang, M. C. M.; Chou, C. J.; Chen, C. F. The vasorelaxing action of rutaecarpine, direct paradoxical effects on intracellular calcium
concentration of vascular smooth muscle and endothelial cells, J Pharmacol Exp Ther, 1996, 276, 1016-1021.
80. Wang, G. J.; Wu, X. C.; Chen, C. F.; Lin, L. C.; Huang, Y. T.; Shan, J.; Pang, P. K. T.;
Vasorelaxing action of rutaecarpine effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells, J Pharamcol Exp Ther, 1999, 289,
1237-1244.
81. Wang, L.; Hu, C. P.; Deng, P. Y. The protective effects of rutaecarpine on gastric mucosa injury in rats, Planta Med, 2005, 71, 416-419.
82. Yamahara, J.; Yamada, T.; Kitani, T.; Naitoh, Y.; Fujimura, H. Antianoxic action and active, constituents of Evodiae fruatus, Chem Pharm Bull, 1989, 1820-1822.
83. Yi, H. H.; Rang, W. Q.; Deng, P. Y. Protective effects of rutaecarpine in cardiac anaphylactic injury is mediated by CGRP, Planta Med, 2004, 70, 1135-1139.
84. Sheu, J. R.; Kan, Y. C.; Hung, W. C.; Su, C. H.; Lin, C. H.; Lee, Y. M.; Yen, M. H. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C, Thrombosis Research, 1998, 92, 53-64.
85. Sheu, J. R.; Hung, W. C.; Lee, Y. M.; Yen, M. H. Mechanism of inhibition of platelet
aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, Eur J Pharmacol, 1996, 318, 469-475.
86. Sheu, J. R.; Hung, W. C.; Wu, C. H. Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in vivo experiments, Br J Haematol, 2000, 110, 110-115.
87. Iwata H.; Tezuka Y.; Kadota S. Mechanism- based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract, Drug Metab
Pharmacokinet 2005, 20, 34-45.
88. Ueng, Y. F.; Ko, H. C.; Wang, J. J.; Chen C. F.; Chen K. T. Modulation of
drug-metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice, Life Sciences, 2002, 71, 1267-1277.
89. Ueng, Y. F.; Wang, J. J.; Lin, L. C.; Park, S. S.; Chen, C. F. Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa, Life Sciences, 2001, 70, 207-217.
90. Lee, S. K.; Kim, N. H.; Lee, J. "Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s", Planta Med, 2004, 70, 753- 757.
91. Moon T. C.; Murakami M.; Kudo I.; A new class of COX- 2 inhibitor: “rutaecarpinefrom Evodia rutaecarpa", Inflamm Res, 1999, 48, 621-625.
92. Jiang, J. K.; Chiu, J. H.; Yu, I. T. In vitro relaxation of rabbit and human internal anal sphincter by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, Life Sci, 2000, 66, 2323-2335.
93. Kobayashi Y.; Nakano Y.; Kizaki M. Capsaicin- like antiobese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist, Planta Med, 2001, 67, 628-633.
94. Beak S. M.; Paek S. H.; Jahng Y. Inhibition of UVA irradiation - modulated signaling pathways by rutaecarpine, a quinazolinocarboline alkaloid, in human keratinocytes, Eur J Pharmacol, 2004, 498, 19-25.
95. Adams M.; Kunert O.; Haslinger E. Inhibition of leukotriene biosynthesis by quinolone alkaloids from the fruits of Evodia rutaecarpa. Planta Med, 2004, 70, 904-908.
96. Tominaga K.; Higuchi K.; Hamasaki N. In vivo action of novel alkyl methyl quinolone alkaloids against Helicobacter pylori, J Antimicrob Chemother, 2002, 50, 547-552.
97. Lin, L. C.; Chou, C. J.; Chen, K. T.; Chen, C. F. Flavonoids from Evoidae fructus, J Chin Med, 1991, 2, 94-100.
98. Chuang, W. C.; Sheu, S. J. A comparative study on processed Evodiae Fructus, Chin Pharm J, 1994, 46, 89-97.
99. Wu, T. S.; Yeh, J. H.; Wu, P. L.; Chen, K. T.; Lin, L. C.; Chen, C. F.
7-Hydroxyrutaecarpine from Tetradium glabrifolium and Tetradium ruticarpum, Heterocycles, 1995, 41, 1071-1076.
100. 江慧玉, 麻黃、厚卜、吳茱萸之成分分析研究, 國立台灣師範大學化學研究所, 碩士論 文, 台北, 2001, pp162-167.
101. Tang, W.; Eisenbrand, G. Evodia rutaecarpa (Juss.) Benth. In: W. Tang and G. Eisenbrand (Eds.), Chinese Drugs of Plant Origin, Springer-Verlag, Berlin, 1992, pp. 509-514.
102. Chang, H.M.; But, P.P.H. Wuzhuyu. In: H.M. Chang and P.P.H. But (Eds.), Pharmacology and Applications of Chinese Materia Medica, World Scientific Publishing Co. Pte. Ltd., Singapore, 1986, pp. 605-609.
103. King, C.L.; Kong, Y.C.; Wong, N.S.; Yeung, H.W.; Fong, H.H.; Sankawa, U. Uterotonic effect of Evodia rutaecarpa alkaloids. J Nat Prod., 1980, 43, 577-582.
104. Wang, G.J.; Shum, A.Y.; Lin, Y.L.; Liao, J.F.; Wu, X.C.; Ren, J.; Chen, C.F. Calcium channel blockade in vascular smooth muscle cells: major hypotensive mechanism of S-petasin, a hypotensive sesquiterpene from Petasites formosanus. J Pharmacol Exp Ther., 2001, 297, 240-246.
105. Arteche, E.; Strippoli, G.; Loirand, G.; Pacaud, P.; Candenas, L.; Molto, J.C.; Souto, L.;
Fernandez, J.; Norte, M.; Martin, J.D.; Savineau, J.P. An analysis of the mechanisms involved in the okadaic acid-induced contraction of the estrogen-primed rat uterus, J Pharmacol Exp Ther., 1997, 282, 201-207.